Damora Therapeutics, Inc. (DMRA): 10-Q filed Aug 10, 2026

Form type

10-Q

Filing date

Aug 10, 2026

Accession number

0001193125-26-342307

Filer

Damora Therapeutics, Inc. (CIK 1800315)